Le Lézard
Classified in: Health, Science and technology, Business
Subject: VEN

Red Arrow Therapeutics Inc. closes $4.5M Seed Extension round


BOSTON, April 23, 2024 /PRNewswire/ -- Red Arrow Therapeutics Inc. closed a $4.5M Seed Extension round, raising from four, top-tier institutional investors in Japan.

Participants of this round are:

This boosts the accumulative funding raised by Red Arrow Therapeutics to nearly $5.5M, along with previous funding from The University of Tokyo Edge Capital Partners Co., Ltd., University of California, Berkeley's accelerator SkyDeck , and other non-dilutive funding.

Emerging from the University of Tokyo's Cabral Lab in 2021, Red Arrow Therapeutics Inc. develops pH-sensing nanomedicine drug delivery technologies for multiple therapeutic areas such as oncology. Headquartered in Boston, Massachusetts, the company is committed to delivering cutting-edge technology for patients in need worldwide.

The Seed extension round will allow Red Arrow Therapeutics to obtain key preclinical data on safety and efficacy of their lead compound, IL-12-loaded nanopolymeric micelles. The funding will also enable manufacturing initiation in collaboration with external partners.

Red Arrow Therapeutics, Inc.

Founders: Takuya Miyazaki, Ph.D. , Horacio Cabral, Ph.D., and Rika Tajima, MPH

Founded Date: August 19, 2021

Address:

Website: https://redarrowtx.com/

Contact: https://redarrowtx.com/contact/

Rika Tajima
[email protected]  

 

SOURCE Red Arrow Therapeutics Inc.


These press releases may also interest you

3 mai 2024
EASTERN PLATINUM LIMITED REPORTS RECORD ANNUAL FULL YEAR REVENUE FOR 2023, ANNOUNCES RESTATEMENT OF COMPARATIVES, AND PROVIDES ITS TARGETS FOR 2024
Eastern Platinum Limited (JSE: EPS) ("Eastplats" or the "Company") is pleased to report that it has filed its Audited Consolidated Financial Statements for the fiscal year ended December 31, 2023 and the corresponding Management's Discussion and...

3 mai 2024
Chemistree Directors Ratify Debenture Restructuring
Chemistree Technology Inc. and (US OTC: CHMJF) (the "Company" or "Chemistree"), announces that its board of directors (the "Board") has approved a restructuring transaction (the "Restructuring Transaction"), pursuant to which all of the principal of...

3 mai 2024
THE CHEMOURS COMPANY SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against The Chemours Company - CC
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 20, 2024 to file lead plaintiff applications in a securities class action lawsuit against The Chemours Company , if they purchased or otherwise acquired...

3 mai 2024
/C O R R E C T I O N -- Nomic DAO Foundation/
In the news release, Nomic Unveils Bitcoin Liquid Staking Token Powered by Babylon's Bitcoin Staking Protocol, issued 10-Apr-2024 by Nomic DAO Foundation over PR Newswire, we are advised by the company that the dateline should read "GEORGE TOWN,...

3 mai 2024
TSX Venture Exchange Stock Maintenance Bulletins
24/05/03 - TSX Venture Exchange Stock Maintenance Bulletins TSX VENTURE COMPANIES BULLETIN V2024-1287 COPPER ROAD RESOURCES INC. ("CRD")BULLETIN TYPE: Declaration of Dividend, Remain HaltedBULLETIN DATE: May 3, 2024TSX Venture Tier 2 Company Copper...

3 mai 2024
WESTSHORE TERMINALS FILES 2024 FIRST QUARTER REPORT AND ANNOUNCES 2024 Q2 DIVIDEND
Westshore Terminals Investment Corporation (the "Corporation") announced today that it has filed its earnings report for the first quarter ended March 31, 2024 and related management's discussion and analysis with the Canadian security regulatory...

More news about Business...


News published on and distributed by: